LENZ Therapeutics LENZ
NASDAQ LENZ
$3.58 -0.21 (-5.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Asset Writedowns and Impairment (2023 - 2026)

Updated

LENZ Therapeutics (LENZ) reported Asset Writedowns and Impairment of $414,000 for Q1 2026, up 404.9% from $82,000 a year earlier.

Analysis

LENZ Therapeutics (LENZ) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends

For FY2025, LENZ Therapeutics posted Asset Writedowns and Impairment of $82,000.

  • By year, Asset Writedowns and Impairment came in at $56.62 million in FY2023.
  • The Q1 2026 figure ranks as the highest quarterly Asset Writedowns and Impairment since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 LENZ Therapeutics 112.47 Mn 112.47 Mn 5.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 414,000.00
Mar 31, 2025 82,000.00
Dec 31, 2023 13.35 Mn
Sep 30, 2023 7.22 Mn
API Access

LENZ Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=LENZ&period=max&api_key=YOUR_API_KEY